Successful Management of Tardive Dyskinesia with Quetiapine and Clonazepam in a Patient of Schizophrenia with Type 2 Diabetes Mellitus
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Tardive dyskinesia is one of the most significant side effects of antipsychotic medications. Antipsychotic treated schizophrenia patients with diabetes mellitus are more likely to develop tardive dyskinesia than those without diabetes. Clozapine is probably best supported for management of tardive dyskinesia. But clozapine has been strongly linked to hyperglycaemia and impaired glucose tolerance, so it is not preferred in patients with diabetes mellitus. We present a case of 35-year-old male with a diagnosis of schizophrenia and type 2 diabetes mellitus with tardive dyskinesia, who was successfully treated with quetiapine and clonazepam.
Abstract
Tardive dyskinesia is one of the most significant side effects of antipsychotic medications. Antipsychotic treated schizophrenia patients with diabetes mellitus are more likely to develop tardive dyskinesia than those without diabetes. Clozapine is probably best supported for management of tardive dyskinesia. But clozapine has been strongly linked to hyperglycaemia and impaired glucose tolerance, so it is not preferred in patients with diabetes mellitus. We present a case of 35-year-old male with a diagnosis of schizophrenia and type 2 diabetes mellitus with tardive dyskinesia, who was successfully treated with quetiapine and clonazepam.
참고문헌 (22)
- Llorca PM, "Tardive dyskinesias and antipsychotics: a review", Eur Psychiatry, 17, pp.129~138 (2002)
- Ganzini L, "The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study", Arch Gen Psychiatry, 48, pp.259~263 (1991)
- Tarsy D, "Epidemiology of tardive dyskinesia:is risk declining with modern antipsychotics?", Mov Disord, 21, pp.589~598 (2006)
- Woerner MG, "Diabetes and development of tardive dyskinesia", Am J Psychiatry, 150, pp.966~968 (1993)
- Ganzini L, "Tardive dyskinesia and diabetes mellitus", Psychopharmacol Bull, 28, pp.281~286 (1992)
- Lévy E, "Diabetes, tardive dyskinesia, parkinsonism, and akathisia in schizophrenia:a retrospective study applying 1998 diabetes health care guidelines to antipsychotic use", Can J Psychiatry, 49, pp.398~402 (2004)
- Fenton WS, "Risk factors for spontaneous dyskinesia in schizophrenia", Arch Gen Psychiatry, 51, pp.643~650 (1994)
- Mukherjee S, "Possible association between tardive dyskinesia and altered carbohydrate metabolism", Arch Gen Psychiatry, 42, pp.205~ (1985)
- Mukherjee S, "Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance", Psychiatry Res, 29, pp.17~27 (1989)
- Mukherjee S, "Neuroleptic-induced movement disorders" (1997), Cambridge University Press
- Schultz SK, "Impaired glucose tolerance and abnormal movements in patients with schizophrenia", Am J Psychiatry, 156, pp.640~642 (1999)
- Duncan D, "Tardive dyskinesia: how is it prevented and treated?", Psychiatr Bull, 21, pp.422~425 (1997)
- Emsley R, "A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia", J Clin Psychiatry, 65, pp.696~701 (2004)
- Kinon BJ, "Olanzapine treatment for tardive dyskinesia inschizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periods", Prog Neuropsychopharmacol Biol Psychiatry, 28, pp.985~996 (2004)
- Kay SR, "The positive and negative syndrome scale (PANSS) for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
- Lane RD, "Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale", J Nerv Ment Dis, 173, pp.353~357 (1985)
- Sernyak MJ, "Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia", Am J Psychiatry, 159, pp.561~566 (2002)
- Vesely C, "Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine", Int Clin Psychopharmacol, 15, pp.57~60 (2000)
- Farah A, "Reduction of tardive dyskinesia with quetiapine", Schizophr Res, 47, pp.309~310 (2001)
- Alptekin K, "Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophrenia", Int Clin Psychopharmacol, 17, pp.263~264 (2002)
- Bhoopathi PS, "Benzodiazepines for neuroleptic-induced tardive dyskinesia", Cochrane Database Syst Rev, (3), pp.CD000205~ (2006)
- Ascher-Svanum H, "Tardive dyskinesia and the 3-year course of schizophrenia: results from a large, prospective, naturalistic study", J Clin Psychiatry, 69, pp.1580~1588 (2008)